Overview

Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment

Status:
Unknown status
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
comparing the effect of using sildenafil citrate and LMWH in treatment of cases of IUGR due to placental insufficiency
Phase:
Phase 3
Details
Lead Sponsor:
Ain Shams University
Treatments:
Calcium heparin
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
Sildenafil Citrate
Tinzaparin